Though many children infected with COVID-19 experience mild symptoms or are asymptomatic, a small subset develop a dangerous complication called MIS-C, or multisystem inflammatory syndrome in children, after being infected by the virus. In a study of children who received a COVID-19 vaccine after recovering from MIS-C, researchers at Baylor College of Medicine and Texas Children’s Hospital found that the vaccine was well-tolerated in this group of patients and there were no serious adverse side effects from the vaccine. Their report appears today in JAMA Network Open.